IM Cannabis (NASDAQ:IMCC – Get Free Report) and Shandong Weigao Medical Polymer (OTCMKTS:SHWGF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, profitability and earnings.
Valuation and Earnings
This table compares IM Cannabis and Shandong Weigao Medical Polymer”s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
IM Cannabis | $39.44 million | 0.27 | -$7.72 million | ($0.54) | -3.74 |
Shandong Weigao Medical Polymer | $1.82 billion | 1.71 | $314.90 million | N/A | N/A |
Volatility & Risk
IM Cannabis has a beta of 2.13, indicating that its stock price is 113% more volatile than the S&P 500. Comparatively, Shandong Weigao Medical Polymer has a beta of -0.28, indicating that its stock price is 128% less volatile than the S&P 500.
Analyst Recommendations
This is a summary of recent ratings and target prices for IM Cannabis and Shandong Weigao Medical Polymer, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
IM Cannabis | 1 | 0 | 0 | 0 | 1.00 |
Shandong Weigao Medical Polymer | 0 | 0 | 0 | 0 | 0.00 |
Insider & Institutional Ownership
7.7% of IM Cannabis shares are held by institutional investors. 5.9% of IM Cannabis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Profitability
This table compares IM Cannabis and Shandong Weigao Medical Polymer’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
IM Cannabis | -4.19% | -59.80% | -5.15% |
Shandong Weigao Medical Polymer | N/A | N/A | N/A |
Summary
Shandong Weigao Medical Polymer beats IM Cannabis on 6 of the 10 factors compared between the two stocks.
About IM Cannabis
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.
About Shandong Weigao Medical Polymer
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregators consumable, blood sampling products, prefilled syringes for pre-pack medication and medical needles which mainly include intravenous needles, syringe needles, intravenous catheter needles, blood sampling needles and irregular needles; orthopedic materials and instruments, including trauma products of steel plates and screws, spinal implants, and artificial joints; and blood purification consumables and equipment, including puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers and related consumables. It also provides tumour and blood vessel interventional instruments; flushing syringes; blood collection, irradiation, storage, separation and sterilization products; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; medical polymer materials and products; injection puncture Instruments; medicines; and X-ray based irradiation machines. In addition, it is involved in the finance leasing and factoring business; provision of enterprise management advisory services, logistics and storage, and computer technical services; and sale of electronic products. The company was incorporated in 2000 and is based in Weihai, the People’s Republic of China.
Receive News & Ratings for IM Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IM Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.